We are live on
!
Find out more
CC
Cannell & Co Portfolio holdings
AUM
$3.15B
1-Year Est. Return
30.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.09%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.67B
AUM Growth
+$18.9M
(+0.71%)
Cap. Flow
-$35.6M
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
264
New
17
Increased
48
Reduced
110
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$50.3M |
| 2 |
Lennar Class A
LEN
|
+$45.6M |
| 3 |
AL
Air Lease Corp
AL
|
+$34.3M |
| 4 |
Walt Disney
DIS
|
+$10.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$9.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$38.5M |
| 2 |
KKR & Co
KKR
|
+$33.1M |
| 3 |
SPR
Spirit AeroSystems
SPR
|
+$24.9M |
| 4 |
Chubb
CB
|
+$21.5M |
| 5 |
Micron Technology
MU
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Technology | 17.91% |
| 3 | Industrials | 13.94% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMBI
251
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $62K | ﹤0.01% |
5,000
| – | – |
|
252
Cineverse
CNVS
$55M
| $52K | ﹤0.01% |
+1,664
| New | +$51.1K |
|
|
EMMA
253
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
| $36K | ﹤0.01% |
3,333
| – | – |
|
254
Kopin
KOPN
$663M
| $31K | ﹤0.01% |
11,000
| – | – |
|
|
MYNDW
255
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
| $4K | ﹤0.01% |
20,000
| – | – |
|
256
Golar LNG
GLNG
$4.95B
| – | – |
-65,150
| Closed | -$1.78M |
|
|
257
KKR & Co
KKR
$89.2B
| – | – |
-1,630,900
| Closed | -$33.1M |
|
258
M&T Bank
MTB
$36.2B
| – | – |
-1,352
| Closed | -$249K |
|
259
Under Armour Class C
UA
$2.92B
| – | – |
-15,298
| Closed | -$220K |
|
260
Under Armour
UAA
$3B
| – | – |
-14,000
| Closed | -$229K |
|
|
EBSB
261
DELISTED
Meridian Bancorp, Inc.
EBSB
| – | – |
-127,664
| Closed | -$2.57M |
|
|
GNMK
262
DELISTED
GenMark Diagnostics, Inc
GNMK
| – | – |
-10,000
| Closed | -$54K |
|
|
GPT
263
DELISTED
Gramercy Property Trust
GPT
| – | – |
-285,318
| Closed | -$6.2M |
|
|
TWX
264
DELISTED
Time Warner Inc
TWX
| – | – |
-5,750
| Closed | -$544K |
|
Similar funds
GW
PMEF
SS
WMSA
GC
WP
BWM
DI
Cannell & Co's Q2 2018 Portfolio in Review
As of Q2 2018, Cannell & Co held 264 positions worth $2.67B, up 0.71% from $2.66B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cannell & Co's Q2 2018 filing shows 17 new, 48 increased, 110 reduced and 9 closed positions. Its largest new stake was Broadcom: 2,051,400 shares worth $49.8M. The largest sale was Celgene Corp, an estimated $38.5M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Cannell & Co's largest Q2 2018 buy was Broadcom: 2,051,400 shares worth $49.8M.
- Cannell & Co added most to Lennar Class A in Q2 2018, an estimated $45.6M increase.
- Cannell & Co's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $38.5M.
- Cannell & Co fully exited KKR & Co in Q2 2018, selling an estimated $33.1M.
- Cannell & Co's ten largest holdings make up 26% of its $2.67B portfolio in Q2 2018.
- Cannell & Co opened 17 new positions and closed 9 in Q2 2018.
- Cannell & Co's portfolio value rose 0.71% quarter-over-quarter to $2.67B.
Based on Cannell & Co's 13F filing for Q2 2018, filed 6 Aug 2018.